DEFERASIROX 180 MG TABLET

DEFERASIROX
$0.8750per EA

Strength

180 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603023201

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

10/22/2025

Active Ingredients

DEFERASIROX

Approval Type

Generic (ANDA)

FDA Application

ANDA214474

On Market Since

10/16/2023

Pharmacological Classes

Cytochrome P450 1A2 Inhibitors
Cytochrome P450 2C8 Inhibitors
Cytochrome P450 3A4 Inducers
Iron Chelating Activity
Iron Chelator

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

0.0%